§ 13F · FUND PROFILE
Pivotal bioVenture Partners Investment Advisor LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $161.3T (13F)Positions · 12Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$43.7T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | PCVX | VAXCYTE INC | 1.37M | $63.3T | 24.5% | ±0% |
| 2 | OCS | OCULIS HOLDING AG | 2.29M | $45.7T | 17.7% | −1% |
| 3 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1.37M | $39.7T | 15.3% | −36% |
| 4 | EVMN | EVOMMUNE INC | 1.93M | $33.0T | 12.8% | NEW |
| 5 | ZBIO | ZENAS BIOPHARMA INC | 592K | $21.5T | 8.3% | −24% |
| 6 | TRVI | TREVI THERAPEUTICS INC | 1.26M | $15.7T | 6.1% | ±0% |
| 7 | IMNM | IMMUNOME INC | 733K | $15.7T | 6.1% | +46% |
| 8 | MPLT | MAPLIGHT THERAPEUTICS INC | 611K | $10.7T | 4.2% | NEW |
| 9 | BIOA | BIOAGE LABS INC | 653K | $8.6T | 3.3% | ±0% |
| 10 | RXRX | RECURSION PHARMACEUTICALS IN | 596K | $2.4T | 0.9% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PIVOTAL SIGNAL
AC read
Pivotal bioVenture Partners Investment Advisor LLC is a Other fund managing $161342.9 trillion in assets. The fund runs a focused portfolio of just 12 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed